Summary: Oxford and Wuhan vaccine trials have shown promise in early testing. Both trial vaccines were well tolerated with no serious adverse reactions according to Lancet, the foremost medical journal. In India too, human trials for made in India vaccine have begun. AIIMS Director in Delhi says, "They will have 100 volunteers for phase 1 trials and will have the data from trials in 3 months. (Video courtesy: University of Oxford)
